Research Paper Volume 15, Issue 20 pp 10996—11011

Figure 4. Analyzing the prognostic value of BTN2A2 in different glioma subgroups. (A–F) Correlation between total survival and glioma grade, IDH mutation, and 1p/19q codeletion status, age, primary therapeutic outcome, and histological types. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001. (G) Construction of a nomogram to determine the OS of patients with glioma. (H) The calibration curve was used to determine the OS of patients from the TCGA cohort.